57 related articles for article (PubMed ID: 15047105)
1. NAD(P)H:quinone oxidoreductase 1 expression, hydrogen peroxide levels, and growth phase in HeLa cells.
Bello RI; Gómez-Díaz C; Navas P; Villalba JM
Methods Enzymol; 2004; 382():234-43. PubMed ID: 15047105
[No Abstract] [Full Text] [Related]
2. Expression of NAD(P)H:quinone oxidoreductase 1 in HeLa cells: role of hydrogen peroxide and growth phase.
Bello RI; Gómez-Díaz C; Navarro F; Alcaín FJ; Villalba JM
J Biol Chem; 2001 Nov; 276(48):44379-84. PubMed ID: 11567026
[TBL] [Abstract][Full Text] [Related]
3. p-nitrosophenol reduction by liver cytosol from ADH-positive and -negative deermice (Peromyscus maniculatus).
Dudley BF; Winston GW
Arch Biochem Biophys; 1995 Feb; 316(2):879-85. PubMed ID: 7532387
[TBL] [Abstract][Full Text] [Related]
4. p53-dependent apoptosis and NAD(P)H:quinone oxidoreductase 1.
Asher G; Lotem J; Sachs L; Shaul Y
Methods Enzymol; 2004; 382():278-93. PubMed ID: 15047108
[No Abstract] [Full Text] [Related]
5. Dicumarol inhibition of NADPH:quinone oxidoreductase induces growth inhibition of pancreatic cancer via a superoxide-mediated mechanism.
Cullen JJ; Hinkhouse MM; Grady M; Gaut AW; Liu J; Zhang YP; Weydert CJ; Domann FE; Oberley LW
Cancer Res; 2003 Sep; 63(17):5513-20. PubMed ID: 14500388
[TBL] [Abstract][Full Text] [Related]
6. Antioxidant response induced by serum withdrawal protects HL-60 cells against inhibition of NAD(P)H:quinone oxidoreductase 1.
Gómez-Díaz C; Bello RI; López-Lluch G; Forthoffer N; Navas P; Villalba JM
Biofactors; 2003; 18(1-4):219-28. PubMed ID: 14695937
[TBL] [Abstract][Full Text] [Related]
7. Quinones and glutathione metabolism.
Watanabe N; Dickinson DA; Liu RM; Forman HJ
Methods Enzymol; 2004; 378():319-40. PubMed ID: 15038978
[No Abstract] [Full Text] [Related]
8. Effect of dicumarol, a Nad(P)h: quinone acceptor oxidoreductase 1 (DT-diaphorase) inhibitor on ubiquinone redox cycling in cultured rat hepatocytes.
Kishi T; Takahashi T; Mizobuchi S; Mori K; Okamoto T
Free Radic Res; 2002 Apr; 36(4):413-9. PubMed ID: 12069105
[TBL] [Abstract][Full Text] [Related]
9. Differentiation-dependent expression of NADP(H):quinone oxidoreductase-1 via NF-E2 related factor-2 activation in human epidermal keratinocytes.
Piao MS; Choi JY; Lee DH; Yun SJ; Lee JB; Lee SC
J Dermatol Sci; 2011 Jun; 62(3):147-53. PubMed ID: 21524888
[TBL] [Abstract][Full Text] [Related]
10. Enhanced activity of the plasma membrane oxidoreductase in circulating lymphocytes from insulin-dependent diabetes mellitus patients.
Lenaz G; Paolucci U; Fato R; D'Aurelio M; Parenti Castelli G; Sgarbi G; Biagini G; Ragni L; Salardi S; Cacciari E
Biochem Biophys Res Commun; 2002 Feb; 290(5):1589-92. PubMed ID: 11820804
[TBL] [Abstract][Full Text] [Related]
11. Characterization of extracellular menadion-catalyzed H2O2 production by NIH/3T3 cells.
Yamashoji S
Biochem Mol Biol Int; 1998 Mar; 44(3):555-63. PubMed ID: 9556217
[TBL] [Abstract][Full Text] [Related]
12. NAD(P)H:quinone oxidoreductase (NQO1) protects astroglial cells against L-dopa toxicity.
Drukarch B; Jongenelen CA; van Muiswinkel FL
Adv Exp Med Biol; 2001; 500():237-40. PubMed ID: 11764945
[No Abstract] [Full Text] [Related]
13. Comparison of the induction of a 4S beta-naphthoflavone-binding protein, cytochrome P450 1A1 and NAD(P)H:quinone oxidoreductase in beta-naphthoflavone-treated rats.
Brauze D
Toxicol Lett; 2004 Sep; 152(2):111-6. PubMed ID: 15302092
[TBL] [Abstract][Full Text] [Related]
14. Human NAD(P)H:quinone oxidoreductase inhibition by flavonoids in living cells.
Lee YY; Westphal AH; de Haan LH; Aarts JM; Rietjens IM; van Berkel WJ
Free Radic Biol Med; 2005 Jul; 39(2):257-65. PubMed ID: 15964517
[TBL] [Abstract][Full Text] [Related]
15. Role of Nad(P)h: quinone oxidoreductase in the regulation of intracellular redox state.
Mohora M
Rom J Intern Med; 2000-2001; 38-39():33-50. PubMed ID: 15529570
[TBL] [Abstract][Full Text] [Related]
16. Chemical structures of inducers of nicotinamide quinone oxidoreductase 1 (NQO1).
Dinkova-Kostova AT; Fahey JW; Talalay P
Methods Enzymol; 2004; 382():423-48. PubMed ID: 15047115
[No Abstract] [Full Text] [Related]
17. Structure and mechanism of NAD[P]H:quinone acceptor oxidoreductases (NQO).
Bianchet MA; Faig M; Amzel LM
Methods Enzymol; 2004; 382():144-74. PubMed ID: 15047101
[No Abstract] [Full Text] [Related]
18. Activation and detoxification of naphthoquinones by NAD(P)H: quinone oxidoreductase.
Munday R
Methods Enzymol; 2004; 382():364-80. PubMed ID: 15047112
[No Abstract] [Full Text] [Related]
19. A likely molecular basis of the susceptibility of Giardia lamblia towards oxygen.
Li L; Wang CC
Mol Microbiol; 2006 Jan; 59(1):202-11. PubMed ID: 16359329
[TBL] [Abstract][Full Text] [Related]
20. Indolequinone antitumour agents: correlation between quinone structure and rate of metabolism by recombinant human NAD(P)H:quinone oxidoreductase.
Newsome JJ; Swann E; Hassani M; Bray KC; Slawin AM; Beall HD; Moody CJ
Org Biomol Chem; 2007 May; 5(10):1629-40. PubMed ID: 17571194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
